How do Doximity, Inc. and Ingevity Corp compare by revenue?

Doximity, Inc. reported revenue of $185.1M in Q3 FY2026, while Ingevity Corp reported $185.4M in Q4 FY2025. Ingevity Corp is 1.0× larger by last-quarter revenue.

Which is growing revenue faster, Doximity, Inc. or Ingevity Corp?

Doximity, Inc.'s latest revenue grew 9.8% year-over-year, versus 36.7% for Ingevity Corp. Ingevity Corp is growing faster on a YoY basis.

Which has a higher gross margin, Doximity, Inc. or Ingevity Corp?

Doximity, Inc.'s gross margin is 89.9% vs Ingevity Corp's 41.2%. Doximity, Inc. converts more of each revenue dollar into gross profit.

Which has a higher net margin, Doximity, Inc. or Ingevity Corp?

Doximity, Inc.'s net margin is 33.3% vs Ingevity Corp's -45.6%. Doximity, Inc. has the higher bottom-line margin.

What is the 2-year revenue CAGR for Doximity, Inc. vs Ingevity Corp?

Over the trailing 8 quarters, Doximity, Inc. compounded revenue at roughly 25.2% per year, versus -26.2% for Ingevity Corp. Doximity, Inc. has the faster medium-term growth trajectory.

Where does this DOCS vs NGVT data come from?

All figures are parsed directly from SEC EDGAR 10-Q / 10-K / 20-F / 6-K filings (for US-listed issuers) or EDINET filings (for Japanese issuers), then normalised into a common schema. Numbers update automatically as new filings are released.

vs

Side-by-side financial comparison of Doximity, Inc. (DOCS) and Ingevity Corp (NGVT). Click either name above to swap in a different company.

Ingevity Corp is the larger business by last-quarter revenue ($185.4M vs $185.1M, roughly 1.0× Doximity, Inc.). Doximity, Inc. runs the higher net margin — 33.3% vs -45.6%, a 78.9% gap on every dollar of revenue. On growth, Ingevity Corp posted the faster year-over-year revenue change (36.7% vs 9.8%). Over the past eight quarters, Doximity, Inc.'s revenue compounded faster (25.2% CAGR vs -26.2%).

Doximity, Inc.DOCSEarnings & Financial Report

NYSE · Information Technology · Services-Computer Programming Services

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

Ingevity CorpNGVTEarnings & Financial Report

NYSE · Materials · Chemicals & Allied Products

Ingevity Corp is a global specialty chemicals and advanced materials manufacturer. It produces high-performance carbon materials, pavement preservation solutions, and specialty chemicals, serving automotive emissions control, industrial purification, road infrastructure, and agricultural input markets across North America, Europe, and Asia Pacific.

DOCS vs NGVT — Head-to-Head

Bigger by revenue

NGVT

1.0× larger

$185.4M

$185.1M

Growing faster (revenue YoY)

NGVT

+27.0% gap

36.7%

9.8%

Higher net margin

DOCS

78.9% more per $

33.3%

-45.6%

Faster 2-yr revenue CAGR

DOCS

Annualised

25.2%

-26.2%

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric	DOCS	NGVT
Revenue	$185.1M	$185.4M
Net Profit	$61.6M	$-84.6M
Gross Margin	89.9%	41.2%
Operating Margin	38.9%	-47.7%
Net Margin	33.3%	-45.6%
Revenue YoY	9.8%	36.7%
Net Profit YoY	-18.1%	-609.6%
EPS (diluted)	$0.31	$-2.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue

DOCS

NGVT

Q4 25	$185.1M	$185.4M
Q3 25	$168.5M	$333.1M
Q2 25	$145.9M	$365.1M
Q1 25	$138.3M	$284.0M
Q4 24	$168.6M	$135.6M
Q3 24	$136.8M	$333.8M
Q2 24	$126.7M	$390.6M
Q1 24	$118.1M	$340.1M

Net Profit

DOCS

NGVT

Q4 25	$61.6M	$-84.6M
Q3 25	$62.1M	$43.5M
Q2 25	$53.3M	$-146.5M
Q1 25	$62.5M	$20.5M
Q4 24	$75.2M	$16.6M
Q3 24	$44.2M	$-107.2M
Q2 24	$41.4M	$-283.7M
Q1 24	$40.6M	$-56.0M

Gross Margin

DOCS

NGVT

Q4 25	89.9%	41.2%
Q3 25	90.3%	40.2%
Q2 25	89.2%	37.8%
Q1 25	89.5%	39.9%
Q4 24	91.6%	81.3%
Q3 24	90.0%	39.4%
Q2 24	89.3%	31.5%
Q1 24	89.4%	29.3%

Operating Margin

DOCS

NGVT

Q4 25	38.9%	-47.7%
Q3 25	37.8%	18.7%
Q2 25	37.4%	-39.1%
Q1 25	35.2%	9.4%
Q4 24	47.4%	—
Q3 24	38.8%	33.0%
Q2 24	36.4%	25.9%
Q1 24	35.5%	22.6%

Net Margin

DOCS

NGVT

Q4 25	33.3%	-45.6%
Q3 25	36.8%	13.1%
Q2 25	36.5%	-40.1%
Q1 25	45.2%	7.2%
Q4 24	44.6%	12.2%
Q3 24	32.3%	-32.1%
Q2 24	32.7%	-72.6%
Q1 24	34.4%	-16.5%

EPS (diluted)

DOCS

NGVT

Q4 25	$0.31	$-2.33
Q3 25	$0.31	$1.18
Q2 25	$0.27	$-4.02
Q1 25	$0.31	$0.56
Q4 24	$0.37	$0.44
Q3 24	$0.22	$-2.94
Q2 24	$0.21	$-7.81
Q1 24	$0.20	$-1.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric	DOCS	NGVT
Cash + ST InvestmentsLiquidity on hand	$64.8M	$78.1M
Total DebtLower is stronger	—	$1.2B
Stockholders' EquityBook value	$979.3M	$29.7M
Total Assets	$1.2B	$1.7B
Debt / EquityLower = less leverage	—	39.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments

DOCS

NGVT

Q4 25	$64.8M	$78.1M
Q3 25	$169.2M	$83.4M
Q2 25	$137.3M	$76.9M
Q1 25	$209.6M	$71.5M
Q4 24	$165.3M	$68.0M
Q3 24	$184.2M	$135.5M
Q2 24	$111.4M	$107.4M
Q1 24	$96.8M	$88.5M

Total Debt

DOCS

NGVT

Q4 25	—	$1.2B
Q3 25	—	$1.2B
Q2 25	—	$1.2B
Q1 25	—	$1.3B
Q4 24	—	$1.3B
Q3 24	—	$1.4B
Q2 24	—	$1.4B
Q1 24	—	$1.4B

Stockholders' Equity

DOCS

NGVT

Q4 25	$979.3M	$29.7M
Q3 25	$1.1B	$138.1M
Q2 25	$1.0B	$120.7M
Q1 25	$1.1B	$234.6M
Q4 24	$1.0B	$195.2M
Q3 24	$961.2M	$214.5M
Q2 24	$913.6M	$284.8M
Q1 24	$901.4M	$568.2M

Total Assets

DOCS

NGVT

Q4 25	$1.2B	$1.7B
Q3 25	$1.3B	$1.8B
Q2 25	$1.2B	$1.9B
Q1 25	$1.3B	$2.1B
Q4 24	$1.2B	$2.0B
Q3 24	$1.1B	$2.2B
Q2 24	$1.1B	$2.3B
Q1 24	$1.1B	$2.6B

Debt / Equity

DOCS

NGVT

Q4 25	—	39.10×
Q3 25	—	8.39×
Q2 25	—	10.24×
Q1 25	—	5.68×
Q4 24	—	6.86×
Q3 24	—	6.52×
Q2 24	—	4.92×
Q1 24	—	2.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric	DOCS	NGVT
Operating Cash FlowLast quarter	$60.9M	$97.1M
Free Cash FlowOCF − Capex	—	$73.5M
FCF MarginFCF / Revenue	—	39.6%
Capex IntensityCapex / Revenue	—	12.7%
Cash ConversionOCF / Net Profit	0.99×	—
TTM Free Cash FlowTrailing 4 quarters	—	$273.5M